ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005

email@asn-online.org

202-640-4660

The Latest on X

Kidney Week

Abstract: TH-PO1153

COVID-19 Pandemic and Peritonitis in Patients with ESKD on Peritoneal Dialysis

Session Information

  • COVID-19
    October 24, 2024 | Location: Exhibit Hall, Convention Center
    Abstract Time: 10:00 AM - 12:00 PM

Category: Coronavirus (COVID-19)

  • 000 Coronavirus (COVID-19)

Authors

  • Shin, Hye Soon, Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea (the Republic of)
  • Kim, Sun Moon, Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea (the Republic of)
  • Cho, Hyunjeong, Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea (the Republic of)
  • Kim, Ji Hye, Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea (the Republic of)
  • Park, Mi Ran, Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea (the Republic of)
  • Kim, Hye-Young, Chungbuk National University Hospital, Cheongju, Chungcheongbuk-do, Korea (the Republic of)
Background

Coronavirus disease 2019 (COVID-19) pandemic has changed patients’ behaviors and social relationships. However, the influence of COVID-19 pandemic on the peritonitis in patients on peritoneal dialysis (PD) remains to be elucidated. Thus, we investigated the impact of COVID-19 pandemic on the incidence and clinical outcome of peritonitis in end-stage kidney disease (ESKD) patients on PD.

Methods

A single-center retrospective study was conducted. Medical records of all the ESKD patients on maintenance PD were reviewed from Jan 2017 to Dec 2022: clinical characteristics, prescription of PD, pathogens, hospitalization, and clinical outcome of peritonitis. We compared the incidence and clinical outcome of peritonitis three years before (2017-2019) and after COVID-19 pandemic (2020-2022).

Results

A total of 572 medical records were analyzed. The incidence of PD-related peritonitis decreased after COVID-19 outbreak. The incidence of peritonitis was 0.187/patient-year in 2017-2019 and 0.120/patient-year in 2020-2022. The microbiologic features were not different. The most common pathogen of peritonitis were gram-positive bacteria. The proportion of peritonitis-related hospitalization and catheter removal associated with treatment failure did not differ between before and after COVID-19 pandemic.

Conclusion

This study suggests that during the COVID-19 pandemic the incidence of PD-related peritonitis was decreased whereas pathogens and hospitalization did not change.